Treatment of Polytraumatisms With Corticoids
NCT00563303 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 150
Last updated 2010-04-23
Summary
Interest of treatment of polytraumatisms with corticoids (hydrocortisone) for patient with relative adrenocortical insufficiency on frequency of nosocomial infection, and hemodynamic complications and organs injuries.
Conditions
- Polytraumatism
Interventions
- DRUG
-
hydrocortisone
200mg/jour (solution of 48mL), Day 1 to Day 4 100mg/jour (solution of 48mL), Day 5 50mg/jour (solution of 48mL), Day 6
- DRUG
-
NaCl
48mL from Day 1 to Day 6
Sponsors & Collaborators
-
Serb
collaborator UNKNOWN -
Nantes University Hospital
lead OTHER
Principal Investigators
-
Mahe Joachim, MD · Nantes University Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 15 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-11-30
- Primary Completion
- 2006-11-30
- Completion
- 2009-07-31
Countries
- France
Study Locations
More Related Trials
-
Physiologic Effects of Steroids in Cardiac Arrest
NCT02790788 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
COrticosteroids in acUte uRticAria in emerGency dEpartment
NCT03545464 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of "in UTERO" Exposure to Glucocorticoids
NCT01367106 ·Status: UNKNOWN ·Phase: NA
-
A Study of LJPC-501 in Paediatric Patients With Hypotension Associated With Distributive or Vasodilatory Shock
NCT03623529 ·Status: UNKNOWN ·Phase: PHASE2
-
Cutaneous Iontophoresis of Iloprost and Treprostinil in Healthy Volunteers
NCT01082484 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Steroid Use in Pediatric Fluid and Vasoactive Infusion Dependent Shock - Pilot Study
NCT02044159 ·Status: COMPLETED ·Phase: PHASE4
-
Inhaled Dornase Alpha to Reduce Respiratory Failure After Severe Trauma
NCT03368092 ·Status: RECRUITING ·Phase: PHASE3
-
Can Trajectory Nor-epinephrine Infiltration Reduce Blood Loss During Percutaneous Nephrolithotomy (PCNL)?
NCT05035303 ·Status: COMPLETED ·Phase: NA
-
Hydrocortisone in Patients of Out-of-hospital Cardiac Arrest
NCT00172354 ·Status: COMPLETED ·Phase: NA
-
Steroids in Patients With Early ARDS
NCT00562835 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Low Doses Corticosteroids as Adjuvant Therapy for the Treatment of Severe H1N1 Flu
NCT01014364 ·Status: TERMINATED ·Phase: PHASE3
-
Diagnosis and Allergen Identification of Perioperative Anaphylaxis
NCT06793163 ·Status: RECRUITING
-
Improving Safety of Antivenom in People Bitten by Snakes
NCT00270777 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase Ⅲ Study of HR19006 Injection in Postsurgical Parenteral Nutrition
NCT05788588 ·Status: UNKNOWN ·Phase: PHASE3
-
6-Methyl-Prednisolone for Multiple Organ Dysfunction Syndrome
NCT00127985 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effects of Hydrocortisone in Endotoxemia in Normal Volunteers
NCT01064986 ·Status: COMPLETED ·Phase: PHASE1
-
Release of Acetylcholine From the Ganglionated Plexus During the Thaw Phase of Cryoballon Pulmonary Vein Ablation (GP RESPONSE Study)
NCT03636100 ·Status: TERMINATED
-
CYclosporine A in Shockable Out-of-hospital Cardiac Arrest ResUScitation
NCT02887807 ·Status: WITHDRAWN ·Phase: PHASE3
-
Comparative Efficacy of IV Dexamethasone vs. Nebulized Terbutaline for Renal Colic Pain in the ED
NCT06980727 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Efficacy and Safety of Lanreotide 120 Milligram (mg) as a Palliative Treatment of Clinical Symptoms Associated With Malignant Intestinal Obstruction in Inoperable Patients
NCT01076803 ·Status: COMPLETED ·Phase: PHASE2
-
Relevance of the Self-assessment of Skills for Self-administration of Adrenaline by Auto-injectors in Patients at Risk of Severe Anaphylactic Reaction (PacAdré)
NCT05404165 ·Status: UNKNOWN
-
Evaluation of Tolerability and Efficacy of Erythropoietin (EPO) Treatment in Spinal Shock: Comparative Study Versus Methylprednisolone (MP)
NCT00561067 ·Status: TERMINATED ·Phase: PHASE3
-
Prevention of Post-Extubation Laryngeal Edema With Intravenous Corticosteroids
NCT00199576 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess Efficacy and Safety of Lanreotide Autogel 120 MG in Treatment of Clinical Symptoms Associated With Inoperable Malignant Intestinal Obstruction
NCT02275338 ·Status: COMPLETED ·Phase: PHASE2
-
Systematic Early Use of Neuromuscular Blocking Agents in ARDS Patients
NCT00299650 ·Status: COMPLETED ·Phase: PHASE4